Trinity Biotech | TRIB - Sales Revenues


Trinity Biotech reported $14.31M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Bio-Rad Laboratories USD 653M 1.4M Sep/2025
EDAP TMS EUR 16.04M 2.48M Jun/2025
J&J USD 24.6B 610M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 21.43B 2.05B Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Tosoh JPY 256.94B 2.93B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025
Veracyte USD 131.9M 1.74M Sep/2025